Literature DB >> 3874902

Specificity, phenotype, and precursor frequency of primary cytolytic T lymphocytes specific for class II major histocompatibility antigens.

H Golding, A Singer.   

Abstract

Most cytolytic T lymphocytes (CTL) recognize class I rather than class II MHC determinants, and relatively little is known about those CTL that do recognize class II MHC determinants. The present study was undertaken to document the specificity, phenotype, and precursor frequency of primary class II allospecific CTL. It was found that class II-allospecific CTL could be consistently generated in vitro from unprimed spleen or thymus populations in the presence of exogenously added helper factors. The class II MHC specificity of both the precursor and CTL effectors activated in primary cultures by Ia-disparate stimulator cells was documented both by blocking experiments with anti-Ia mAb and by the use of L cell transfectants. The mechanism by which primary allospecific CTL effectors lysed their targets appeared to involve direct cell-cell contact, because they failed to lyse bystander target cells. The frequency in unprimed spleen populations of precursor CTL specific for class II alloantigens was examined by limiting dilution analysis and was found to be as high as 1/15,000 splenocytes and approximately 10% of the frequency reported for primary class I allospecific CTL. Finally, the Lyt phenotype of primary class II allospecific CTL precursors and effectors was determined. It was found that anti-class II CTL derive from at least two distinct precursor subpopulations that are either L3T4+Lyt-2- or L3T4-Lyt-2+, and that the Lyt phenotype expressed by the CTL effectors are concordant with that of their precursors. No correlation was found between the I subregion gene products recognized by CTL effectors and the Lyt phenotype they expressed in that both I-A- and I-E-specific CTL were both L3T4+Lyt-2- and L3T4-Lyt-2+.

Mesh:

Substances:

Year:  1985        PMID: 3874902

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  CD4 cytotoxic and dendritic cells in the immunopathologic lesion of Sjögren's syndrome.

Authors:  G Xanthou; N I Tapinos; M Polihronis; I P Nezis; L H Margaritis; H M Moutsopoulos
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

2.  Inhibition of T-cell mediated cytotoxicity by Novobiocin suggests multiple pathways for both CD4+ and CD8+ cytotoxic T cells.

Authors:  P J Wood; A G Stansfield
Journal:  Immunology       Date:  1992-07       Impact factor: 7.397

3.  Heterogeneous cytotoxic cells that kill NC-sensitive WEHI-164 tumor cells are activated in allogeneic mixed lymphocyte reactions.

Authors:  S Macphail; O Stutman
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

4.  Increased number of CD4-CD8+ MHC class II-specific T cells in MHC class II-deficient mice.

Authors:  S Marusić-Galesić; P Walden
Journal:  Immunology       Date:  1995-07       Impact factor: 7.397

5.  Intestinal graft-versus-host disease is initiated by donor T cells distinct from classic cytotoxic T lymphocytes.

Authors:  D L Thiele; M L Eigenbrodt; S E Bryde; E H Eigenbrodt; P E Lipsky
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

6.  Induction of cutaneous graft-versus-host disease by local injection of unprimed T cells.

Authors:  K Kawai; Y Matsumoto; H Watanabe; M Ito; M Fujiwara
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

7.  Cell-cell interaction in graft rejection responses: induction of anti-allo-class I H-2 tolerance is prevented by immune responses against allo-class II H-2 antigens coexpressed on tolerogen.

Authors:  S Hori; S Kitagawa; H Iwata; T Ochiai; K Isono; T Hamaoka; H Fujiwara
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

8.  Profound atrophy of the bone marrow reflecting major histocompatibility complex class II-restricted destruction of stem cells by CD4+ cells.

Authors:  J Sprent; C D Surh; D Agus; M Hurd; S Sutton; W R Heath
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

9.  Characterization of the lymphocyte activation gene 3-encoded protein. A new ligand for human leukocyte antigen class II antigens.

Authors:  E Baixeras; B Huard; C Miossec; S Jitsukawa; M Martin; T Hercend; C Auffray; F Triebel; D Piatier-Tonneau
Journal:  J Exp Med       Date:  1992-08-01       Impact factor: 14.307

10.  Phenotype, specificity, and function of T cell subsets and T cell interactions involved in skin allograft rejection.

Authors:  A S Rosenberg; T Mizuochi; S O Sharrow; A Singer
Journal:  J Exp Med       Date:  1987-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.